Prosecution Insights
Last updated: May 29, 2026

Aquavit Pharmaceuticals Inc.

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready

Portfolio Summary

4
Total Pending OAs
1
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (75%)
0
Easy (0%)
1
Unknown (25%)

Rejection Statute Mix

BucketCases
§103 only3 (75%)
No statute on record1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
25% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PRAGANI, RAJAN 1 50.0% +73.5%
SMALE, AVERY E 1 72.9% +22.2%
FAY, ZOHREH ALEMZADEH 1 51.8% -6.7%
ZOU, NIANXIANG 1 64.3% +24.2%

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17909688 SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN SUBJECTS USING MICROCHANNEL DELIVERY DEVICES ZOU, NIANXIANG 81d overdue
18025790 SKIN MASK COMPOSITIONS AND METHODS OF USE PRAGANI, RAJAN 71d overdue
18008037 METHODS FOR DELIVERING BIOACTIVE COMPOSITIONS AND FORMULATIONS TO THE SKIN USING MICROCHANNEL DELIVERY DEVICE SMALE, AVERY E 30d

Top Art Units

Art UnitApps
1614 1
3783 1
1617 1
1671 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18025790 SKIN MASK COMPOSITIONS AND METHODS OF USE PRAGANI, RAJAN 1614 §103 Non-Final OA 71d overdue Pending Mar 10, 2023
18008037 METHODS FOR DELIVERING BIOACTIVE COMPOSITIONS AND FORMULATIONS TO THE SKIN USING MICROCHANNEL DELIVERY DEVICE SMALE, AVERY E 3783 §103 Final Rejection 30d Pending Dec 02, 2022
18008049 METHODS AND COMPOSITIONS FOR DELIVERING BIOACTIVE COMPOSITIONS TO OCULAR TISSUE USING MICRONEEDLE DEVICES FAY, ZOHREH ALEMZADEH 1617 §103 Final Rejection 60d overdue Pending Dec 02, 2022
17909688 SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN SUBJECTS USING MICROCHANNEL DELIVERY DEVICES ZOU, NIANXIANG 1671 Other Final Rejection 81d overdue Pending Sep 06, 2022

Managing Aquavit Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month